Skip to main content

Advertisement

Log in

Blood N-terminal pro-brain natriuretic peptide and interleukin-17 for distinguishing incomplete Kawasaki disease from infectious diseases

  • Research Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To explore the diagnostic value of blood N-terminal pro-brain natriuretic peptide (NT-proBNP) and interleukin-17(IL- 17) for incomplete Kawasaki disease.

Methods

Patients with Kawasaki disease, Incomplete Kawasaki disease and unclear infectious fever were included in this retrospective study. Their clinical features, and laboratory test results of blood NT-proBNP and IL-17 were collected and compared.

Results

766 patients with complete clinical information were recruited, consisting of 291 cases of Kawasaki disease, 74 cases of incomplete Kawasaki disease, and 401 cases of unclear infectious diseases. When the consistency with indicator 2 and 3 in Kawasaki disease diagnosis criteria was assessed with blood IL-17 ≥11.55 pg/mL and blood NT-proBNP ≥ 225.5 pg/dL as the criteria, the sensitivity and specificity for distinguishing incomplete Kawasaki disease and infectious diseases reached 86.5% and 94.8%, respectively. When we chose the consistency with indicator 1 and 2 in Kawasaki disease diagnosis criteria, the appearance of decrustation and/or the BCG erythema, blood IL-17 ≥11.55 pg/mL and blood NT-Pro BNP ≥225.5 pg/dL as the criteria, the sensitivity and specificity for distinguishing incomplete Kawasaki disease and infectious diseases was 43.2% and 100%, respectively.

Conclusion

Blood NT-proBNP and IL-17 are useful laboratory indicators for distinguishing incomplete Kawasaki disease and infectious diseases at the early stage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr. 2012;171:651–6.

    Article  PubMed  Google Scholar 

  2. Muta H, Ishii M, Yashiro M, Uehara R, Nakamura Y. Late intravenous immunoglobulin treatment in patients with Kawasaki disease. Pediatrics. 2012;129:e291–7.

    Article  Google Scholar 

  3. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708–33.

    Article  PubMed  Google Scholar 

  4. Penack O, Beinert T, Buchheidt D, Einsele H, Hebart H, Kiehl MG, et al. Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2006;85:424–33.

    Article  PubMed  Google Scholar 

  5. Cho SY, Kim Y, Cha SH, Suh JT, Han MY, Lee HJ. Adjuvant Laboratory Marker of Kawasaki Disease; NTpro-BNP or hs-CRP. Ann Clin Lab Sci. 2011;41:360–3.

    CAS  PubMed  Google Scholar 

  6. No SJ, Kim DO, Choi KM, Eun LY. Do predictors of incomplete Kawasaki disease exist for infants? Pediatr Cardiol. 2013;34:286–90.

    Article  PubMed  Google Scholar 

  7. Iwashima S, Ishikawa T. B-type natriuretic peptide and Nterminal pro-BNP in the acute phase of Kawasaki disease. World J Pediatr. 2013;9:239–44.

    Article  CAS  PubMed  Google Scholar 

  8. Di Yazhen, Wu Ling, Li Yunyan, Ma Tianrui, Wang Tianbo, Lin Yahong, et al. The clinical value of plasma Nterminal pro-brain natriuretic peptide and serum albumin in the early diagnosis of incomplete Kawasaki disease. Chinese J Rheumatol. 2013;9:595–600.

    Google Scholar 

  9. Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S. Gene expression of cytokines (TNF-alpha, IFN-gamma), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Lupus. 2012;21:1105–12.

    Article  CAS  PubMed  Google Scholar 

  10. Omoyinmi E, Hamaoui R, Pesenacker A, Nistala K, Moncrieffe H, Ursu S, et al. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford). 2012;51:1881–6.

    Article  CAS  Google Scholar 

  11. Jia S, Li C, Wang G, Yang J, Zu Y. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol. 2010;162:131–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Jadidi-Niaragh F, Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacol Immunotoxicol. 2012;34:727–39.

    Article  CAS  PubMed  Google Scholar 

  13. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181:8–18.

    Article  CAS  PubMed  Google Scholar 

  14. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11:763–76.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yazhen Di.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, L., Chen, Y., Zhong, S. et al. Blood N-terminal pro-brain natriuretic peptide and interleukin-17 for distinguishing incomplete Kawasaki disease from infectious diseases. Indian Pediatr 52, 477–480 (2015). https://doi.org/10.1007/s13312-015-0659-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-015-0659-1

Keywords

Navigation